|
| Press Releases |
|
 |
|
| Tuesday, October 19, 2021 |
|
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain |
| Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company's novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for the treatment of treatment-resistant depression and chronic pain. more info >> |
|
| Tuesday, August 10, 2021 |
|
|
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership |
| Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan. more info >> |
|
| Friday, July 9, 2021 |
|
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia |
| The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. more info >> |
|
| Monday, June 28, 2021 |
|
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth |
| The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region. more info >> |
|
| Friday, June 4, 2021 |
|
|
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. more info >> |
|
| Thursday, May 27, 2021 |
|
|
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for Phase ll studies in Australia. more info >> |
|
| Friday, May 7, 2021 |
|
|
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. more info >> |
|
| Thursday, April 22, 2021 |
|
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. more info >> |
|
| Friday, March 12, 2021 |
|
|
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. more info >> |
|
| Friday, February 26, 2021 |
|
|
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones |
| The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Merck & Co., Inc., Rahway, NJ, USA and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma
Oct 28, 2025 0:30 JST
|
|
|
Mitsubishi Heavy Industries Machinery Systems to Exhibit at Japan Mobility Show 2025
Oct 28, 2025 0:00 JST
|
|
|
Fujitsu AI transforms regional healthcare in Iki city
Oct 28, 2025 23:24 JST
|
|
|
Hitachi announces initiatives aligned with Japan - U.S. strategic investments
Oct 28, 2025 22:34 JST
|
|
|
NEC Achieves Cisco Gold Provider Status, Strengthening Global Strategic Partnership in the AI era
Oct 28, 2025 22:09 JST
|
|
|
OctoHorizon: Where Engineering Shapes the Future of Trading
Oct 28, 2025 21:00 HKT/SGT
|
|
|
GMG Achieves Major Commercial Milestone - THERMAL-XR(R) to be Distributed Through Australian Beijer Ref and Kirby Network
Oct 28, 2025 20:09 HKT/SGT
|
|
|
The 20th Eco Expo Asia opens today
Oct 28, 2025 19:03 HKT/SGT
|
|
|
Radisson Step-Out Drilling at O'Brien Gold Project Intersects High-Grade Mineralization in Multiple Locations
Oct 28, 2025 18:39 HKT/SGT
|
|
|
Sany Heavy Industry Co., Ltd.'s Hong Kong IPO: "A+H" Dual Platform Anchors a New Journey of Globalization
Oct 28, 2025 15:55 HKT/SGT
|
|
|
TransNusa Celebrates Historical Milestone as it Starts Operating 17 Scheduled Flights Weekly for its Perth-Bali Route
Oct 28, 2025 10:13 HKT/SGT
|
|
|
International Leo Tolstoy Peace Prize 2025 Highlights Central Asian Cooperation 
Oct 27, 2025 23:00 HKT/SGT
|
|
|
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)
Oct 27, 2025 22:00 HKT/SGT
|
|
|
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
Oct 27, 2025 21:00 HKT/SGT
|
|
|
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
Oct 27, 2025 20:45 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
